title: Adenomyosis: what is new?
abstract: Adenomyosis is described as the benign invasion of endometrium into the myometrium, with endometrial glands and stroma surrounded by the hypertrophic and hyperplastic myometrium. It may affect 20% of female population and most widely seen among perimenopausal and multiparous women. Its etiopathogenesis, diagnosis, clinical findings and current various treatment options will be discussed in this article.
authors: Department of Obstetrics & Gynecology, Division of Reproductive Endocrinology, IVF Unit, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey.|Barbaros Bulvari, 69/8-10, Besiktas, Istanbul, 34330, Turkey.
authors: Levent M
authors: LM
authors: Senturk
authors: Department of Obstetrics & Gynecology, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey.
authors: Metehan
authors: M
authors: Imamoglu
mesh_terms: D062788:Adenomyosis / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D003271:Contraceptive Agents, Female / Q000627:therapeutic use; D004343:Drug Implants; D004717:Endometrium / Q000473:pathology*; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D008595:Menorrhagia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D047648:Perimenopause; D012307:Risk Factors; D016387:Women's Health
chemical_list: D003271:Contraceptive Agents, Female; D004343:Drug Implants
keywords: LNG-IUS; MRI; adenomyosis; dysmenorrhea; endometrial glands; endometrial stroma; infertility; intramyometrial cysts; junctional zone; leiomyoma; menorrhagia; ultrasonography